Prior learning: Introduction to peer reviews
This page gives markup examples for members registering peer reviews by direct deposit of XML. It is not currently possible to register the peer reviews content type using one of our helper tools.
Registration of peer reviews is supported as of schema version 4.4.1. Peer reviews include referee reports, decision letters, and author responses. You may also register post-publication reviews using our peer review content type.
Peer review metadata includes a number of review-specific elements. Many are optional to accommodate differences in review practices, but please include all elements relevant to your reviews when submitting your metadata records.
Our schema includes support for the following fields:
contributor, to capture reviewer name and role, choose from:
titlereview_dateinstitutioncompeting_interest_statementrunning_numberlicense datarelationsstagetyperecommendationrevision-roundlanguageNote that all reviews must include relationship metadata linking the review with the item being reviewed. Learn more about structural metadata.
| Element | Description | Limits |
|---|---|---|
| contributor, includes person_name or anonymous | Captures reviewer name and role. If anonymous, must capture as Peer review roles are: reviewer, review-assistant, stats-reviewer, reviewer-external, reader, translator, author, editor |
optional |
| title | Title of review. If you don’t have a review-specific title convention, we recommend that you include Review (or member’s own term for review) in your peer review registration, as well as a revision and review number. For example, a review pattern of Review: title of article (Revision number/Review number) will be: Review: Analysis of the effects of bad metadata on discoverability (R2/RC3) |
required |
| review_date | Date of review, including month, day, year | year is required |
| institution | Organization (member or other) submitting the peer review, strongly advised if submitter differs from publisher of item being reviewed | optional, may include up to 5 |
| competing_interest_statement | Competing interest statement provided by review author during review process | optional |
| running_number | Internal number/identifier used to identify specific review | optional |
| license data | Text or data mining license info | optional |
| relations | Relate review to item being reviewed through relationships - must supply the DOI of item being reviewed as an inter-work relation with review type isReviewOf |
required |
Some metadata is captured as attributes with specific enumerated values:
| Attributes | Description | Limits |
|---|---|---|
| stage | Options are pre-publication and post-publication |
optional |
| type | Types of report include: referee-report, editor-report, author-comment, community-comment, aggregate, recommendation |
optional |
| recommendation | Values are: major-revision, minor-revision, reject, reject-with-resubmit, accept |
optional |
| revision-round | Revision round number, first submission is defined as revision round 0 | optional |
| language | Language of review | optional |
<program xmlns="https://www.crossref.org/relations.xsd">
<related_item>
<description>Referee report of Treatment of plaque psoriasis with an ointment
formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized
clinical trial</description>
<inter_work_relation relationship-type="isReviewOf" identifier-type="doi"
>10.1186/s12895-016-0051-4</inter_work_relation>
</related_item>
</program>
<?xml version="1.0" encoding="UTF-8"?>
<doi_batch xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.crossref.org/schema/4.4.2 http://www.crossref.org/schema/crossref4.4.2.xsd"
xmlns="http://www.crossref.org/schema/4.4.2" version="4.4.2">
<head>
<doi_batch_id>20170807</doi_batch_id>
<timestamp>2017080715731</timestamp>
<depositor>
<depositor_name>Crossref</depositor_name>
<email_address>support@crossref.org</email_address>
</depositor>
<registrant>Crossref</registrant>
</head>
<body>
<peer_review stage="pre-publication" revision-round="1" recommendation="accept">
<contributors>
<person_name contributor_role="reviewer" sequence="first">
<given_name>Wilson</given_name>
<surname>Liao</surname>
</person_name>
</contributors>
<titles>
<title>Review: Treatment of plaque psoriasis with an ointment formulation of the Januskinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial. V1</title>
</titles>
<review_date>
<month>08</month>
<day>19</day>
<year>2016</year>
</review_date>
<competing_interest_statement> There were no competing interests</competing_interest_statement>
<running_number>RC1 </running_number>
<program xmlns="http://www.crossref.org/relations.xsd">
<related_item>
<description>Referee report of Treatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial</description>
<inter_work_relation relationship-type="isReviewOf" identifier-type="doi"
>10.1186/s12895-016-0051-4 </inter_work_relation>
</related_item>
</program>
<doi_data>
<doi>10.5555/abc123</doi>
<resource>https://www.example.org/openpeerreview/art%3A10.1186%2Fs12895-016-0051-4/12895_2016_51_ReviewerReport_V2_R1.pdf</resource>
</doi_data>
</peer_review>
</body>
</doi_batch>